Document Detail


Evaluation of the effect of food on the pharmacokinetics of avitriptan.
MedLine Citation:
PMID:  9737819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bioavailability of avitriptan was found to decrease significantly when administered 5 min after a standard high fat meal. The studies described herein were carried out to gain insight into the mechanism of this food effect. A series of studies were conducted in humans to assess the effect of timing of meal, type of meal, gastric pH, change in the formulation and dose on the bioavailability of avitriptan. Avitriptan was administered as a 50 mg capsule under fasted condition and at 30 min, 1, 2 and 4 h after a standard high fat meal. The reduction in avitriptan bioavailability persisted even at 4 h post high fat meal, although as the time interval between the meal and dose increased, the effect of meal tended to decrease. Bioavailability of avitriptan also decreased significantly when the drug was administered after a high protein and a high carbohydrate meal. Elevation in gastric pH caused by food was not found to be responsible for the food-related decrease in bioavailability of avitriptan since ranitidine pretreatment did not lead to a decrease in bioavailability. When administered as a 50 mg 14C-labeled solution after a standard high fat meal, bioavailability of avitriptan decreased although the decrease was less compared with that observed for a capsule dosage form. Plasma concentrations and cumulative urinary excretion of total radioactivity also decreased in the fed condition, indicating the absorption of avitriptan was affected. The decrease in avitriptan AUC was somewhat more pronounced than the decrease in the exposure to the total radioactivity suggesting a food-related increase in the first-pass metabolism of avitriptan. Effect of the standard high fat meal on avitriptan administered as a 150 mg capsule was similar to that observed at the 50 mg dose. Overall, the results indicate that bioavailability of avitriptan is significantly reduced irrespective of the type of meal, dose and dosage form and the effect persists for as long as 4 h post meal. Thus, it appears that avitriptan absorption and bioavailability are highly sensitive to presence of food in the stomach and any food-related changes in gastric emptying time and gastrointestinal motility.
Authors:
P H Marathe; D S Greene; G D Kollia; R H Barbhaiya
Related Documents :
9465759 - Physiologic effects of cisapride on gastric emptying after pylorus-preserving gastrecto...
3584609 - Measuring feed intake patterns and meal size of lactating dairy cows.
2040469 - Gastrointestinal adaptation to diets of differing fat composition in human volunteers.
6686779 - Reversible hypercholesterolaemia produced by cholesterol-free fish meal protein diets.
7828009 - Genetic parameters from factorial cross breeding in two duck strains (anas platyrhyncho...
15922489 - Meal size of high-fat food is reliably greater than high-carbohydrate food across exter...
16518529 - Interactions among habitual physical activity, eating patterns, and diet composition.
6293939 - Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile chole...
534319 - 1 alpha-hydroxycholecalciferol and calcium deficiency osteoporosis in adult rats.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Biopharmaceutics & drug disposition     Volume:  19     ISSN:  0142-2782     ISO Abbreviation:  Biopharm Drug Dispos     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-19     Completed Date:  1998-11-19     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  7911226     Medline TA:  Biopharm Drug Dispos     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  381-94     Citation Subset:  IM    
Affiliation:
Department of Metabolism and Pharmacokinetics and Biostatistics and Data Management, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, Princeton, NJ 08543, USA. Punit_H._Marathe@ccmail.bms.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Area Under Curve
Biological Availability
Cross-Over Studies
Dietary Carbohydrates / administration & dosage,  pharmacology*
Dietary Fats / administration & dosage,  pharmacology*
Dietary Proteins / administration & dosage,  pharmacology*
Female
Food-Drug Interactions*
Gastric Emptying
Humans
Hydrogen-Ion Concentration
Indoles / administration & dosage,  pharmacokinetics*
Male
Postprandial Period
Ranitidine / pharmacology
Serotonin Agonists / administration & dosage,  pharmacokinetics*
Sulfonamides / administration & dosage,  pharmacokinetics*
Tryptamines
Vasoconstrictor Agents / administration & dosage,  pharmacokinetics*
Chemical
Reg. No./Substance:
0/Dietary Carbohydrates; 0/Dietary Fats; 0/Dietary Proteins; 0/Indoles; 0/Serotonin Agonists; 0/Sulfonamides; 0/Tryptamines; 0/Vasoconstrictor Agents; 171171-42-9/BMS 180048; 66357-35-5/Ranitidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood disposition and urinary excretion kinetics of methazolamide following oral administration to h...
Next Document:  Uptake of verteporfin by articular tissues following systemic and intra-articular administration.